Coronary thrombosis/thrombolysis in pigs: effects of heparin, asa, and the thrombin inhibitor inogatran-Reference-Cited by-同舟云学术

Coronary thrombosis/thrombolysis in pigs: effects of heparin, asa, and the thrombin inhibitor inogatran

Published:1998-03 Issue:2 Volume:39 Page:81-89
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Uriuda Yozo,Wang Qing-Dong,Hatori Nobuo,Nordlander Rolf,Sjöquist Per-Ove,Mattsson Christer,Rydén Lars

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference29 articles.

1. Thrombolytic effects of a novel modified tissue plasminogen activator, E 6010, on coronary thrombosis in the pig;Adachi;Jpn J Pharmacol,1992

2. Precordial ST segment mapping. A sensitive technique for the evaluation of myocardial injury;Capone;Chest,1975

3. Selective coronary embolization in closed-chest dogs;Chagrasulis;Am J Physiol,1977

4. Inogatran, a novel direct low molecular weight thrombin inhibitor, given with but not after tissue-plasminogen activator, improves thrombolysis;Chen;J Pharm Exp Ther,1996

5. ASA does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis;Chen;Circ Res,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of large animal myocardial infarction models (review);Acta Physiologica Hungarica;2012-12

2. A porcine model of ischemic heart failure produced by chronic placement of a tube in a coronary artery;European Journal of Heart Failure;2003-10

3. Synthetic Inhibitors of Thrombin and Factor Xa;Thrombosis Research;1999-03

4. Antithrombotic drugs;Emerging Drugs;1999-01